NAL in their ann. in late july stated
Medical technologies group Norwood Abbey Ltd [ASX:NAL] advises that the commercialisation phase
of the needle-free injection system project is progressing.
During the past six months, the company has received unsolicited approaches, in relation to the
technology, from a number of sources. Preliminary discussions have been undertaken with a number
of parties.
The parties include prominent pharmaceutical groups, one medical consulting group and a number of
research hospitals, all of whom have expressed interest in the human applications of the technology.
Two groups have approached the company regarding veterinary applications of the technology..........
No idea if its the reason for s.p.increase , but its a possibility..
- Forums
- ASX - By Stock
- NAL
- ssupicious activity
ssupicious activity, page-6
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity